← FDA Drug Approvals (Drugs@FDA)

LUBIPROSTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HUMANWELL PURACAP · Approved 2026-10-14

Drug application

FDA Application #

ANDA221049

Application type

Abbreviated New Drug Application (Generic)

Brand name

LUBIPROSTONE

Generic name

Lubiprostone

Active ingredients

LUBIPROSTONE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HUMANWELL PURACAP

First approval

2026-10-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown